Carestream taps new India director

AuntMinnie.com staff writers
Jul 26, 2009

Carestream Health India has appointed Prabir Chatterjee as managing director.

Chatterjee moves to his new assignment after serving as a finance director at Carestream's regional headquarters in Geneva. In his new post, Chatterjee will be responsible for Carestream Health's business and operations in India, Bangladesh, Bhutan, Nepal, and Sri Lanka, according to Carestream Health India of Mumbai.

Related Reading

Carestream nets digital x-ray orders, July 22, 2009

Carestream sells RIS/PACS to Tufts, July 16, 2009

Carestream plans new CR cassette launch, July 9, 2009

Carestream awarded RIS/PACS order, June 19, 2009

Carestream begins shipping new DRX-1 unit, June 18, 2009

Copyright © 2009 AuntMinnie.com

Latest in Clinical News
Maddahi
What impact will flurpiridaz F-18 have on heart care?
October 4, 2024
Breast Mammo Computer
AI scoring predicts future breast cancer risk
October 4, 2024
The Results are in for the 2024 SALARY SCAN
Sponsored
The Results are in for the 2024 SALARY SCAN
September 12, 2024
Pink Ribbon Social
Experts talk breast imaging's 2024 for Breast Cancer Awareness Month
October 3, 2024
Related Stories
187x200 Am Logo
Companies
AuntMinnie.com
Carestream Health Logo
Vendor Neutral Archive
Carestream Health
2009 07 24 14 21 59 537 Fig3 Thumb
Breast
DMIST finds variability between FFDM systems
The Results are in for the 2024 SALARY SCAN
Sponsor Content
The Results are in for the 2024 SALARY SCAN
More in Clinical News
What impact will flurpiridaz F-18 have on heart care?
By Will Morton
Seventeen years was all it took for flurpiridaz F-18 to reach the market, with the first patient injected with the PET imaging agent in November, 2007.
October 4, 2024
Maddahi
AI scoring predicts future breast cancer risk
By Amerigo Allegretto
AI scoring could help predict future breast cancer risk and identify high-risk women.
October 4, 2024
Breast Mammo Computer
CDC considers chest x-ray AI for TB screening program
By Will Morton
The U.S. CDC is considering the use of AI to back up its tuberculosis screening program for immigrants and refugees.
October 3, 2024
XRAI (left) and GradCAM (right) heatmaps for true positive images. The original radiographs are on the left, the Grad-CAM activations and heatmaps are in the middle, and the XRAI activations and overlays are on the right. For the XRAI overlays, only regions reaching the 70th percentile of activation strength are shown. Images available under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0 International) and courtesy of PLOS Digital Health.
Experts talk breast imaging's 2024 for Breast Cancer Awareness Month
By Amerigo Allegretto
As the U.S. celebrates this year's Breast Cancer Awareness Month, radiology experts and advocates reflect on the big year breast imaging has had.
October 3, 2024
Pink Ribbon Social
ASTRO: Shorter radiation course safe for breast reconstruction
By Amerigo Allegretto
Research presented at the ASTRO annual meeting shows that a shorter course of postmastectomy radiation combined with breast reconstruction is safe.
October 2, 2024
Breast Cancer3 400
CEM has tradeoffs for imaging extremely dense breasts
By Amerigo Allegretto
Contrast-enhanced mammography (CEM) has tradeoffs when it comes to imaging women with extremely dense breasts.
October 1, 2024
2024 10 01 Radiology Cem Thumbnail
MRI serves as 'early warning system' for brain tumor growth
By Kate Madden Yee
A daily MR imaging technique can quantify tumor changes in glioblastoma patients undergoing MRI-guided radiation therapy.
October 1, 2024
Brain
Ultrasound test detects 96% of ovarian cancers
By Kate Madden Yee
An ultrasound test can identify 96% of ovarian cancers in postmenopausal women, researchers have reported.
October 1, 2024
Ovarian Cancer
ACS: Breast cancer mortality decreases, disparities persist
By Amerigo Allegretto
A new ACS report found that although overall breast cancer mortality continues to decline, racial and ethnic disparities persist.
October 1, 2024
Breast Mammo 400
PET identifies risk of metastases in patients with HNSCC
By Will Morton
PET imaging with F-18 fluoromisonidazole can determine whether cancer may spread in patients undergoing chemoradiotherapy for head and neck squamous cell carcinoma (HNSCC).
October 1, 2024
Headandneck2
ASTRO: Timing key to adding immunotherapy to chemoradiation
By Amerigo Allegretto
Timing may be key when adding immunotherapy to chemoradiation for lung cancer treatment.
October 1, 2024
Lung Cancer
ASTRO: Black patients voice distrust in medical research
By Will Morton
Spiritual beliefs and a distrust of clinical research may partly explain why Black patients choose not to participate in cancer trials.
September 30, 2024
Black Patient
Page 1 of 3611
Next Page